Medical Communications

Bristol-Myers Squibb has announced that Giovanni Caforio has been appointed chairman of the board. Caforio will take up the position …

Seattle Genetics released that the FDA had placed a hold had been placed on clinical trials involving its experimental cancer …

Pfizer has announced that they have acquired AstraZeneca’s small molecule anti-infectives business for an upfront fee of $550 million. Pfizer …

There have been new revelations regarding the fatal French clinical trial that occurred in January of this year. Nature reports …

Teva Pharmaceuticals, the world’s largest generics company, has been hit with the largest criminal fine to come from the US …

2016 Top Markets Report

As we’re now in the New Year, here at Pharmafocus, we thought we would do a recap of the ten …

Merrimack Pharmaceuticals announced that it had decided to stop a Phase 2 study of MM-302, a HER2 antibody-targeted liposomal doxorubicin, …

Impax Laboratories announced on 20 December that CEO Frederik Wilkinson has left his position of president and CEO, as well …

What will be the key industry trends in 2017?Industry uncertaintyPerhaps the biggest hallmark of 2016-going-into-2017 is the sense of hesitation …

Fluor Corporation has won an engineering, procurement and construction management contract for Novo Nordisk’s $2 billion diabetes active pharmaceutical ingredient …

The Actelion takeover saga continues with Johnson & Johnson back in the game, and now re-entering into exclusive negotiations. Actelion …

Sun Pharma has announced that it will acquire Odomzo from Novartis for an upfront fee of $175 million alongside additional …

The Colombian government has lowered the price of Glivec (imatinib) by 44%, a cancer drug made by Novartis. The case …

The FDA has released figures to show that drug approvals have fallen from last year’s high of 45 new drugs …